Edition:
India

Emergent BioSolutions Inc (EBS.N)

EBS.N on New York Stock Exchange

48.33USD
22 Mar 2019
Change (% chg)

$-0.67 (-1.37%)
Prev Close
$49.00
Open
$48.89
Day's High
$49.88
Day's Low
$48.31
Volume
226,934
Avg. Vol
145,476
52-wk High
$73.83
52-wk Low
$46.93

Chart for

About

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical... (more)

Overall

Beta: 1.27
Market Cap(Mil.): $1,669.07
Shares Outstanding(Mil.): 41.21
Dividend: --
Yield (%): --

Financials

  EBS.N Industry Sector
P/E (TTM): 29.50 29.30 32.54
EPS (TTM): 1.37 -- --
ROI: 7.33 14.23 13.82
ROE: 10.48 15.46 15.24

Emergent-Valneva Zika vaccine clears early trial

A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

20 Nov 2018

Emergent-Valneva Zika vaccine clears early trial

Nov 19 A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

20 Nov 2018

Earnings vs. Estimates